These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4011670)

  • 1. How does the patient prefer his lithium treatment?
    Vestergaard P
    Pharmacopsychiatry; 1985 May; 18(3):223-4. PubMed ID: 4011670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of the dissolution rate of lithium tablets on side-effect.
    Borg KO; Jeppsson J; Sjögren J
    Acta Pharm Suec; 1974 May; 11(2):133-40. PubMed ID: 4609300
    [No Abstract]   [Full Text] [Related]  

  • 4. The practical management of lithium treatment.
    Schou M; Amdisen A; Baastrup PC
    Br J Psychiatry; 1975; Spec No 9():76-84. PubMed ID: 1102043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium absorption from sustained-release tablets (Duretter).
    Amdisen A; Sjögren J
    Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
    [No Abstract]   [Full Text] [Related]  

  • 7. [Administration of a slow-acting lithium preparation (preliminary report)].
    Molchan I; Motylova A; Khalabala I
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1241-3. PubMed ID: 899543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetic properties of the delayed-action form of lithium carbonate].
    Kabes J; Kabesová L
    Cesk Psychiatr; 1983 Apr; 79(2):102-6. PubMed ID: 6407766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of lithium adverse effects between a short-term (Quilonum) and a depot preparation (Lithium Duriles)].
    Matussek N; von Hessling P
    Nervenarzt; 1971 Jul; 42(7):376-8. PubMed ID: 5561070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of contemnol tablets (lithium retard Spofa)].
    König L; Lange E
    Psychiatr Neurol Med Psychol (Leipz); 1987 Apr; 39(4):230-3. PubMed ID: 3110815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated sustained-release lithium carbonate administration to cats.
    Marini JL; Williams SP; Sheard MH
    Toxicol Appl Pharmacol; 1978 Mar; 43(3):559-67. PubMed ID: 653727
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets.
    Persson G
    Acta Psychiatr Scand; 1974; 50(2):174-82. PubMed ID: 4853671
    [No Abstract]   [Full Text] [Related]  

  • 13. Liquid lithium vs. solid lithium: an open, cross-over, pilot study comparing oral preparations.
    Heiman MF; Schwabach G; Tupin J
    Dis Nerv Syst; 1976 Jan; 37(1):9-11. PubMed ID: 1106967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of a "sustained release" lithium preparation.
    Persson G
    Acta Psychiatr Scand Suppl; 1971; 221():33-8. PubMed ID: 5286326
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the pharmacokinetics of a new application form of lithium with protracted effect (author's transl)].
    Motýlová A; Molcan J; Chalabala M
    Cesk Psychiatr; 1978 Jun; 74(3):133-8. PubMed ID: 699123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of long-acting lithium carbonate--micalite--in the treatment of affective psychoses].
    Khvilivitskiĭ TIa; Mikhalenko IN; Zlatikina GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):583-7. PubMed ID: 868433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical administration of lithiumaspartate].
    Consbruch U; Orth M; Degkwitz R
    Arzneimittelforschung; 1974 Aug; 24(8):1077-9. PubMed ID: 4479527
    [No Abstract]   [Full Text] [Related]  

  • 20. Accuracy and safety of a priori lithium loading.
    Kook KA; Stimmel GL; Wilkins JN; Spangher GG
    J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.